<- Go home

Added to YB: 2019-08-11

Pitch date: 2019-08-11

AVRO:US [bullish]

AVROBIO, Inc.

-92.69%

current return

Author Info

No bio for this author

Company Info

As of June 20, 2024, AVROBIO, Inc. was acquired by Tectonic Therapeutic, Inc., in a reverse merger transaction.

Market Cap

$62.9M

Pitch Price

$229.68

Price Target

N/A

Dividend

N/A

EV/EBITDA

0.58

P/E

2.08

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
AVROBIO INC COM AVRO:US

A summary for this pitch has not been created yet.

Read full article (0 min)